Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-07-14

Clinical Trial Update: A Study of the Effects of Minocycline on Cognitive Function After Carotid Endarterectomy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating minocycline for cognitive outcomes after carotid endarterectomy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Minocycline (minocycline)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Carotid Stenosis | Phase 2 | Status: WITHDRAWN